The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1433
January 6, 2014
View Complete Issue         Table of Contents 2019 
New Oral Anticoagulants for Acute Venous Thromboembolism
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
New Oral Anticoagulants for Acute Venous Thromboembolism
January 6, 2014 (Issue: 1433)
Anticoagulants are the drugs of choice for treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), collectively referred to as venous thromboembolism (VTE).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: New Oral Anticoagulants for Acute Venous Thromboembolism
Article code: 1433b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.